3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Melanoma
10
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Uveal Melanoma
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Advanced Cancer
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Turcot syndrome
1
Thyroid Neoplasms
1
Tertiary Lymphoid Structures
1
Spinocerebellar Degenerations
1
Sarcoma
1
Interventions
Doxorubicin
62
Ifosfamide
39
Gemcitabine
29
Radiotherapy
27
Filgrastim
27
Cyclophosphamide
26
Docetaxel
19
Vincristine
18
pembrolizumab
17
Etoposide
17
pazopanib
16
Cisplatin
16
Nivolumab
15
Trabectedin
14
apatinib
13
Magnetic Resonance Spectroscopy
13
Carboplatin
12
Irinotecan
11
Bevacizumab
11
Temozolomide
10
Sirolimus
10
camrelizumab
9
anlotinib
9
Surgical Procedures, Operative
9
Sorafenib
9
Paclitaxel
9
Ipilimumab
9
Injections
9
Dactinomycin
9
Topotecan
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Sarcoma
×
relatlimab
×
Clear all
NCT04095208
2026-04-21
CONGRATS
Institut Bergonié
Phase 2
Completed
68 enrolled